Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT05677347 · COMPLETED
Trial details
- NCT number
- NCT05677347
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2023-07-20
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.